Topic Coronavirus
Duke scholars are working to advance our understanding of COVID-19, from basic science to translational medicine to clinical care—as well as to address concerns related to the pandemic from a variety of disciplines.
Top Story
Recent Stories
-
Nasher Museum Returns to Pre-Pandemic Hours This Week
Free admission for everyone; café and museum open til 9 p.m Thursdays
-
Inflation and Omicron: Don’t Panic, Don’t Hoard, Experts Advise
-
Taking New Aim at COVID-19
The coronavirus’s tangled strands of RNA could offer new ways to treat people who get infected
-
Duke to Distribute Additional Federal Emergency Grants to Students
Higher Education Emergency Relief Fund (HEERF) supports students with exceptional need
-
COVID Vaccine for Kids is Best Protection From Illness, Death
Dr. Emmanuel Walter Jr., a pediatrician and chief medical officer at the Duke Human Vaccine Institute, briefs media
-
University COVID-19 Testing Results for Oct. 11-17
-
University COVID-19 testing results for Oct. 4-10
-
Meet Duke’s COVID-19 Lead Contact Tracers
The staff and faculty wellness program strives to stay a step ahead of the virus on campus
-
News Tip: Expert Available on Pfizer’s EA Request for Child Vaccine
Dr. Emmanuel Walter, director of the Duke Vaccine and Trials Unit, says vaccine “lead to an excellent immune response in children”
-
Duke Experts Discuss COVID Vaccines for Children, Myths Aimed at Spanish-Speaking Communities
Pediatrician says her own children will be vaccinated as soon as FDA issues approval
In the News
Former FDA Chief Talks Timetable on Omicron-Specific Vaccine — With Hope We Never Need It
Interview with Dr. Mark McClellan, director of the Duke-Margolis Health Policy Center
Results Expected Next Week From U.S. Labs Testing Vaccines’ Strength Against Omicron
Features the work of professor David Montefiori and his team at Duke University Medical Center
Omicron Propels U.S. Booster Drive Where It’s Needed Least
Quotes Dr. Jonathan Quick, an adjunct professor at the Duke Global Health Institute
Omicron Is Already in the U.S. End Discriminatory Travel Bans for Southern Africa
Commentary by April Raphiou, communications director at the Duke Center for International Development in the Sanford School of Public Policy
Your Brain Doesn’t Like Uncertainty — and That Will Help You Cope With COVID
Commentary by Kevin S. LaBar, associate chair of the Department of Psychology & Neuroscience at Duke
New COVID Pills Offer Hope as Omicron Looms
Features the work and comments of Amanda Hargrove, associate professor of chemistry at Duke
Test Developed at Duke Can Quickly Tell Who’s Got Antibodies to Fight Which Coronavirus Variant
Covers Duke research; quotes Dr. Cameron Wolfe, associate professor of medicine at the Duke University School of Medicine
Duke Experts Feel General Public Should Be More Careful During Holidays Amid Omicron Variant
Covers a media briefing with infectious disease specialist Dr. Cameron Wolfe and professor David Montefiori
Editorial: United States Must Do More to Vaccinate the World
Quotes Dr. Krishna Udayakumar, the director of Duke University’s Global Health Innovation Center
Biden to Make At-Home Testing Free; Over the Counter Test Results Not Included in State COVID-19 Data
Interview with Thomas Denny, a professor of medicine with the Duke Human Vaccine Institute